Spencer Peter S, Palmer Valerie S, Kisby Glen E
Department of Neurology, School of Medicine, and Oregon Institute of Occupational Health Sciences, Oregon Health & Science University, Portland, OR, USA.
Department of Neurology, School of Medicine, and Oregon Institute of Occupational Health Sciences, Oregon Health & Science University, Portland, OR, USA.
J Neurol Sci. 2020 Dec 15;419:117185. doi: 10.1016/j.jns.2020.117185. Epub 2020 Oct 15.
Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex (ALS-PDC) is a disappearing neurodegenerative disorder of apparent environmental origin formerly hyperendemic among Chamorros of Guam-USA, Japanese residents of the Kii Peninsula, Honshu Island, Japan and Auyu-Jakai linguistic groups of Papua-Indonesia on the island of New Guinea. The most plausible etiology is exposure to genotoxins in seed of neurotoxic cycad plants formerly used for food and/or medicine. Primary suspicion falls on methylazoxymethanol (MAM), the aglycone of cycasin and on the non-protein amino acid β-N-methylamino-L-alanine, both of which are metabolized to formaldehyde. Human and animal studies suggest: (a) exposures occurred early in life and sometimes during late fetal brain development, (b) clinical expression of neurodegenerative disease appeared years or decades later, and (c) pathological changes in various tissues indicate the disease was not confined to the CNS. Experimental evidence points to toxic molecular mechanisms involving DNA damage, epigenetic changes, transcriptional mutagenesis, neuronal cell-cycle reactivation and perturbation of the ubiquitin-proteasome system that led to polyproteinopathy and culminated in neuronal degeneration. Lessons learned from research on ALS-PDC include: (a) familial disease may reflect common toxic exposures across generations, (b) primary disease prevention follows cessation of exposure to culpable environmental triggers; and (c) disease latency provides a prolonged period during which to intervene therapeutically. Exposure to genotoxic chemicals ("slow toxins") in the early stages of life should be considered in the search for the etiology of ALS-PDC-related neurodegenerative disorders, including sporadic forms of ALS, progressive supranuclear palsy and Alzheimer's disease.
肌萎缩侧索硬化症与帕金森痴呆综合征(ALS-PDC)是一种正在消失的神经退行性疾病,显然源于环境因素,以前在美国关岛的查莫罗人、日本本州岛纪伊半岛的日本居民以及新几内亚岛印度尼西亚巴布亚的奥尤-贾凯语族中高度流行。最合理的病因是接触以前用于食品和/或药物的神经毒性苏铁植物种子中的基因毒素。主要怀疑对象是甲基偶氮甲醇(MAM),它是环孢素的苷元,还有非蛋白质氨基酸β-N-甲基氨基-L-丙氨酸,这两种物质都会代谢为甲醛。人类和动物研究表明:(a)接触发生在生命早期,有时发生在胎儿脑发育后期,(b)神经退行性疾病的临床症状在数年或数十年后出现,(c)各种组织的病理变化表明该疾病并不局限于中枢神经系统。实验证据指向涉及DNA损伤、表观遗传变化、转录诱变、神经元细胞周期重新激活以及泛素-蛋白酶体系统紊乱的毒性分子机制,这些机制导致多蛋白病并最终导致神经元变性。从ALS-PDC研究中吸取的教训包括:(a)家族性疾病可能反映了几代人共同的有毒接触,(b)主要疾病预防措施是停止接触有害的环境触发因素;(c)疾病潜伏期提供了一个较长的治疗干预期。在寻找与ALS-PDC相关的神经退行性疾病(包括散发性ALS、进行性核上性麻痹和阿尔茨海默病)的病因时,应考虑生命早期接触基因毒性化学物质(“慢毒素”)的情况。